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Maltese substance misusing mothers have significantly different socio-biological 
characteristics from mothers in the general population which seem to impact on neonatal 
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Clinical Article 
 
Word Count: 2578 
 
 
 
 
 
 
 
 
 
 
 
3 
 
3 
 
Abstract 
Objectives: The aim of the study was to identify the prevalence and sociobiological 
characteristics of Maltese pregnant substance misusing mothers (SMM) as compared to the 
general maternity population.  
Methods: All SMM attending the national Substance Misuse Outpatients Unit and receiving 
methadone during 2000-2009 were included in the study (n=182). The socio-biological 
characteristics of the pregnant women and their newborns were statistically compared with a 
control group (n=329) randomly selected from the general maternity population from the 
national obstetric database. SPSS was used to compare and analyse the data. 
Results: The prevalence of SMM receiving care was 0.43%. SMM were significantly younger 
(P<0.0005), out-of-wedlock (P<0.001), multiparous (P<0.001) and cigarette smokers 
(P<0.001). SMM sought antenatal care later in gestation (P=0.013). Neonates of the SMM 
had a lower birth weight (P<0.005) and had smaller head circumferences (P=0.03). 
Conclusions: SMM have significantly different socio-biological characteristics from mothers 
in the general Maltese population which seem to impact on neonatal outcomes. 
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Introduction 
The degree of use of illicit substances such as cocaine, heroin and cannabis during pregnancy 
has increased over the last decades, especially in the younger population. An estimated 
30,000 pregnant women use illicit opioids each year in the European Union (Gyarmathy et 
al., 2009) According to the European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA), data on the prevalence of drug use among pregnant women is not available for 
most European countries; and where available, often comes from isolated studies using 
various methodologies making the observations not readily comparable (EMCDDA 2012). In 
an Ibiza Hospital, 16% of mothers giving birth had used illicit drugs during the third trimester 
of their pregnancy when assessed by a hair analysis although only 2% of the mothers had 
reported drug use during their pregnancy (EMCDDA 2012). In Latvia, the National Registry 
of mothers at Childbirth in the Czech Republic reported a prevalence of 1.8% of illicit drug 
use among over 1 million mothers between 2000 and 2009. However, only 0.2% and 0.8% of 
mothers delivering live births or stillbirths respectively reported illicit drug use (EMCDDA 
2012).  
In Malta, 15-25 newborns out of an average of 4000 live births annually (0.4-0.6%) are 
reportedly exposed to opioids and/or cocaine (Sedqa - The National Maltese agency against 
dependencies: internal unpublished data). Although data about pregnant substance-misusing 
women in Malta, has been methodically collected for more than 10 years by the National 
Obstetric Information System (NOIS) Register and Sedqa, little has been written about this 
special population. According to the last national Census, the Maltese population in 2011 
consisted of 416,055 inhabitants with a male: female ratio of 1000:1008 (Census of 
population and housing n Malta 2012).  A previous study carried out in this population during 
1998-2002 showed that the proportion of reported substance misusing mothers (SMM) was 
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0.24% (Savona-Ventura, 2004). The present study, using a more comprehensive data 
collection system, sought to review the prevalence of SMM and compare the socio-biological 
characteristics and obstetric outcomes of pregnancy in SMM to non-drug misusing mothers 
between 2000 and 2009 in order to identify any differing trends between the two groups.  
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Methods 
All Maltese SMM attending the Substance Misusing Out-Patients Unit, (SMOPU) run by 
Sedqa, and who were pregnant and gave birth between the years 2000-2009 (n = 182) were 
compared with a randomized representative sample of the general Maltese maternal 
population delivering during the same period (n = 329). The randomized sample was made 
available by the Department of Health Information and Research from the NOISR which 
records all maternities occurring on the Islands. It accounted for 0.9% of all maternities. The 
SMM were all prescribed a daily dose of methadone linctus (range 20 – 100 mg, prescribed 
concentration of 1 mg/ml). Use of illicit substances was also noted: those common in Malta 
are heroin, cocaine 3,4-methylenedioxy-N-methylamphetamine (MDMA/ Ecstasy) and 
cannabis. It was not possible to differentiate poly drug usage in the retrospective data. 
The socio-biological characteristics and obstetric outcomes of both groups were compared; 
including maternal age at delivery, marital status, parity, mother’s educational background, 
cigarette use and mode of delivery. Infant data up to 30 days after delivery was also similarly 
compared. Infant data included birth weight and head circumference, the Apgar score at 1 and 
5 minutes, the feeding methods employed and the length of hospital stay.   
Ethical approval for the study was granted by the University of Malta Research Ethics 
Committee. The Department of Health Information and Research further gave its approval to 
access its national data-base. SPSS (version 21) was used to compare and analyse the data. 
Data was assessed using chi square analysis and the level of significance employed was 0.05. 
Other tools used were the one-way ANOVA test, Independent Samples T-test and Logistic 
Regression. 
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Results 
In the ten-year study period investigated, i.e., 2000-2009, there were a total of 35,362 
pregnancies of which 182 (0.43%) SSM attended Sedqa. The SMM were generally younger 
(mean age 25 ± 5.4 years) when compared to Maltese mothers who had not misused 
substances (28.2± 5.6 years. n = 329; t = 6.225, P<0.001). The mean age of the first 
pregnancy, was also documented. In SMM it was similarly lower than that in the general 
population (21.9 ± 4.2 years n = 72 vs. 25.8 ± 5.2 years: n = 166; P<0.001). SMM were 
significantly more likely to be out-of-wedlock than their non-abuser counterparts (P<0.001) 
(Table I). The SMM had significantly higher parity (P = 0.001) with an average of 1.07 ± 
1.11 children (range 1 to 4) when compared to the general population who had 0.73 ± 5.42 
children (range 1 to 4). The educational background was documented and SMM were found 
to be less likely to have completed post-secondary education. A greater proportion of SMM 
left the educational system at primary school level (P =0.007) (Table I).  
 
SMM were more likely to smoke cigarettes regularly, with more than half (n = 99; 54.7%) 
smoking more than 3 cigarettes daily (control: n = 10; 3.1%). A further 6.6% (n = 12) of 
SMM admitted to smoking ≤3 cigarettes per day (control: n = 4; 1.2%). SMM reported a 
significantly greater likelihood of continuing smoking during their pregnancy than their 
counterparts (P <0.001) (Table I). Only one SMM admitted to problematic alcohol use, no 
woman in the control group reported abusing alcohol. The SMM were all in treatment at the 
SMOPU and prescribed methadone (range from 20 -100 ml): some mothers also used illicit 
drugs in additional to their methadone prescription, while yet others were poorly compliant 
taking methadone on certain days and missing their dose on other days as recorded in their 
medical notes.  
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SMM were more likely to seek professional antenatal advice later in pregnancy than mothers 
from the general population (mean: 21.2 ± 20.4 weeks; range 18.2 to 24.2 weeks vs. 17.0 ± 
17.1, range 15.1 to 18.8 weeks, P value= 0.013). The maternal body weight at term was 
significantly lower in SMM than in mothers from the general population (73.7 ± 14.7 kg, 
range 70.9-76.6 kg vs. 77.2 ± 14.1kgs; range: 75.3 – 79.0 kg; P = 0.04) (Table I). This 
difference persisted even when the maternal weight was corrected for the eventual birth 
weight of the child. A higher proportion of SMM were predicted and investigated antenatally 
for a small-for-gestational age infant (13.7% vs. 7.9%, P = 0.036). There were three SMM 
who suffered from hypertensive disease during pregnancy in contrast to none of the controls. 
There were no statistical differences in the proportions of SMM mother requiring Caesarean 
section compared to the general population (73.5% vs. 70.5%, P = 0.52). The SMM also 
showed no significant difference in their choice of analgesia during labour (none or 
inhalational 79.1% vs. 72.7%; opioid ± inhalational 17.0% vs. 24.9%; regional alone or in 
combination 3.8% vs. 2.4%, P = 0.11). However, the mean gestational age of delivery of 
SMM pregnancies was significantly lower than that in controls 33.3 UNITS NEEDED HERE 
weeks??+ 2.0 vs 34.0 + 1.6, P = 0.003). 
 
Infants born to SMM had a lower mean birth weight than those born to the general population 
(P < 0.0005). The difference in birth weight between the two groups persisted even when 
corrected for the degree of cigarette smoking (Table II). The mean size of the head 
circumference of the infants born to SMM was smaller than their counterparts born to the 
general population (P = 0.003) (Table II). The Apgar scores after 1 and 5 minutes for the 
infants born to SMM were significantly lower than the Apgar values of infants of the non-
abusers (P =0.014 after 1 minute; P <0.001 after 5 minutes). Infants of SMM had a 
significantly longer hospital stay (P < 0.001) and were less likely to be breastfeed than their 
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counterparts (Table II). The infants born to SMM all survived the first four weeks of life. In 
contrast, there were three stillbirths and two early neonatal deaths registered in the control 
group [perinatal mortality rate: 15.2 per 1000 total births].  
Discussion 
The present study has suggested that over the ten-year period, 2000-2009, the proportion of 
pregnant SMM was 0.43%. This rate appears to have doubled from the figure of 0.24% 
reported in the same population during the period 1998-2002 (Savona-Ventura, 2004). While 
this near double increase may reflect an increase in drug abuse in the reproductive age, it is 
much more likely that SMM are coming forward to avail themselves of the Sedqa services 
more than previously. Sedqa services are provided with complete confidentiality without any 
recourse or mandatory reporting to the law enforcing agencies. 
SMM have been shown in this retrospective study to have specific sociobiological 
characteristics compared to their non-substance misuse counterparts. SMM were thus 
significantly younger than the general pregnant population and had their first pregnancy 
significantly earlier. This finding has been observed elsewhere in other European countries 
and in North America (Cleary et al., 2011). These differences may be attributed to many 
possible causes. One could hypothesise that under the influence of psychoactive substances, 
young girls are less prone to use contraceptives or more likely to engage in more risky 
behaviour (Thangappah, 2000). They may also be using sex to pay for their habit.  
It should be noted that in Malta termination of pregnancy for whatever reason remains illegal, 
though women with unwanted pregnancies can choose to have their pregnancy terminated 
overseas. This option may not be a viable one for SMM because of financial difficulties. 
Furthermore, Maltese SMM were often single, lacking the support of a partner (Fischer & 
Kopf, 2007) and as observed in other studies were unsure of the identity of the child’s father 
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and/or were involved in prostitution (Savona-Ventura, 2004). They were more likely to be 
multiparous. While this could reflect resorting to prostitution to pay for their needs, it may be 
a reflection of the social benefits system available in the Maltese Islands. Unmarried Maltese 
women qualify for financial support from the Department of Social Services, and a 
significant proportion of women delivering out of legal wedlock remain single to avail 
themselves of the financial benefits. In such cases, the child would have no legal father and 
no legal rights to paternal support.  
(https://secure3.gov.mt/socialpolicy/social_benefits/sa/soc_assist_single_par/info_soc_assist_
single_par). It has been previously reported in other studies that siblings of the same SMM 
often have different fathers (Black et al., 2012) and often face financial hardships (Roberts, 
2003). A SMM who is single and having to support herself and her child contributes to 
difficulties that are made worse by poor educational attainment (Rini et al; 1999). The 
Maltese SMM have been shown to have attained a lower educational level. 
Maltese SMM also had significant medical care issues. They booked their pregnancy 
significantly later than the general control population, as has been previously reported in the 
literature (Cleary et al; 2011, Savona-Ventura, 2004, Thangappah, 2000). Consequently, any 
medical or obstetric problem arising during pregnancy would be identified and addressed 
late. The reasons for the delay in booking are unclear, especially since the Maltese National 
Health Service provides free medical services for all stages of pregnancy. It is thought 
probable that late booking may be caused by a failure to recognise that conception has 
occurred (Jones et al; 2011) as a result of opioid induced menstrual irregularity (Grönbladh & 
Öhlund, 2011). Once in treatment, illicit opioid use may decrease, reinstating ovulation, and 
increasing the risk of unplanned pregnancy (Fischer & Kopf, 2007). 
The present study has shown that SMM weighed less at the end of pregnancy than their 
counterparts. Women on opioids do tend to neglect their overall health and nutrition starting 
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pregnancy in a relatively ‘malnourished’ state. Mothers on opioids appear to be particularly 
susceptible to hyperemesis gravidarum in the first trimester further contributing to their 
malnutrition. Even afterwards, their eating habits are not regular (Thangappah, 2000). The 
low maternal weight at term could also have been contributed by the observed reduction in 
mean birth weight of the infant. 
Fetal growth effects after opioid exposure in utero, such as lower birth weight, smaller head 
circumference and lower Apgar scores were demonstrated in this study. These may be a 
direct opioid effect but other confounding variables could also have contributed to the 
observed fetal adverse outcomes. Variables influencing fetal growth and gestational age at 
delivery include smoking, multiple drug use and low socioeconomic status: all factors being 
prevalent in SMM in the present and previous studies (Cleary et al; 2011, Fischer & Kopf, 
2007, Simpson, 1957). While heroin has been associated with retarded fetal growth (Bada et 
al 2002, Minnes et al; 2011, Minozzi et al; 2008), the use of methadone has been shown to  
be associated with higher birth weights when compared to women who continued to use 
heroin. It has further been shown to HELP prevent premature labour so that fetuses exposed 
to methadone had a higher birth weight and less morbidity than heroin exposed babies 
(Finnegan et al; 2010). This was attributed to the fact that SMM on methadone maintenance 
had better antenatal care. It is relevant to note that in the present study, the SMM babies 
weighed less and were smaller than those from the general population irrespective of reported 
smoking habits. No information was unfortunately available in the study in respect to opioid 
use during pregnancy other than methadone. The associated low Apgar may be explained by 
the direct effect of opioids on the new-born’s brain which affects its respiratory system 
(Angeles et al; 2007).  
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Finally, despite general encouragement towards breastfeeding, since it has been found to 
decrease the occurrence and severity of the Neonatal Abstinence Syndrome (Jansson et al; 
2004, MacCarthy & Posey, 2000, O’Connor et al; 2013, Pritham, 2013), fewer SMM chose to 
breast feed when compared to the general population. SMM neonates also had a longer 
hospital stay in excess of the standard Maltese departmental policy of keeping these infants 
hospitalized for a minimum of seven days. 
Conclusions 
This retrospective study has confirmed some of the findings described in other populations. 
SMM tend to be younger, out-of-wedlock, of lower educational background, multiparous, 
and more likely to smoke cigarettes. Their newborns were more likely to have lower Apgar 
scores at one and 5 minutes after birth, tended to be artificially fed and had a longer hospital 
stay. Contradictory to other previous reports, the SMM newborns tended to have low birth 
weights even though their mothers were receiving methadone irrespective of the degree of 
cigarette smoking: unreported illicit drug use may have been a confounding factor. This can 
be considered to be the main limitation of the present study since the NOIS data collection 
system does not require documentation of other medications or illicit drug use. 
In order to improve the treatment outcomes for pregnant SMM, care should be coordinated 
by multidisciplinary interventions, encompassing personal and social welfare, gynaecological 
and obstetric care, and care for drug use (Doggett et al; 2005, Fischer & Kopf, 2007,  Terplan 
& Lui, 2007). The aim of such care is to reduce risk to the mother and child through the 
integrated collaboration of obstetricians, addiction counsellors, social workers, general 
practitioners and other health care specialists, to link drug treatment with other interventions 
aimed to help pregnant SMM (Gyarmathy et al; 2009, Wright & Walker, 2007) 
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Women who misuse drugs during pregnancy are an elusive population who often remain 
unidentified to practitioners and researchers and hence have generally not been well studied. 
SMM have definite socio-biological characteristics that should influence healthcare 
professional and public health officials to modify current health promotion strategies to better 
address this target population.  
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Table I: Demographic data for control mothers (n = 329) and SMM (n = 182). 
 
 SMM Control P value 
Age at first pregnancy 
Mean age (years) 
n=72 
21.9 ± 4.2  
n=166 
25.8 ± 5.2  
P< 0.001 
Marital Status: 
Out of wedlock 
Married 
 
n= 150     82.4% 
n= 32       17.6% 
 
n=72     21.9% 
n=257   78.1% 
 
P<0.001 
Educational Status: 
Primary 
Secondary 
Post Secondary 
 
n=2         1.1% 
n=52      28.6% 
n=0          0% 
 
n=1         0.3% 
n=90     27.4% 
n=19       5.8% 
 
 
P= 0.007 
Cigarette Smoking: 
No Cigarettes 
≤3 cigarettes 
>3 cigarettes 
 
n=70       38.7% 
n=12         6.6% 
n=99       54.7% 
 
n=310       95.7% 
n=4             1.2% 
n=10           3.1% 
 
P< 0.001 
Mothers booked 
pregnancy at hospital: 
Weeks (range) 
 
21±20.4  
(18.2 – 24.2)  
 
 
17±17.1 
(15.1 – 18.8) 
 
P = 0.013 
Number of offspring 
Mean (range) 
1.07±1 
 (1-4)  
0.73±5.42  
(1-4) 
P = 0.001 
Mother’s weight at term: 
(kg) 
Mean± SD (range) 
 
73.7±14.7 
(70.9 – 76.6)  
 
77.2 ± 14. 
(75.3 ± 79.0)  
 
 
P = 0.04 
SMM= Substance Misusing Mothers 
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Table II: Infant outcomes of SSM (n = 182) and Control (n = 329) patient groups.  
 
Parameter  
 
SMM (n =182) 
Mean ± SD (range) 
Control (n=329) 
Mean ± SD (range) 
P value 
   Birth weight (gm): 
 
2884.5 ± 569.1 
(2801.0– 2968.0) 
3203.9 ± 549.5 
(3144.3 – 3263.5) 
P < 0.0005 
 
Birth weight of infants 
exposed to nicotine (gm): 
 
2859.5 ± 584.1 
(2749.2 – 2969.9) 
 
3180.6 ± 499.1 
(2892.5 – 3468.8) 
 
P = 0.05 
 
Birth weight of infants not 
exposed to nicotine (gm): 
 
 
2933.1 ± 544.4 
Range:2803.3– 3062.9 
 
3205.5 ± 554.2 
Range: 3143.5 – 3267.4 
 
P < 0.001 
Head Circumference (cm):  
 
33.3 ± 2.0  
Range: 32.98 – 33.7 
34.1 ± 2.52 
Range: 33.8 – 34.4 
P= 0.003 
APGAR after 1 minute 
(score out of 10) 
8.31 ± 1.81 
Range: 8.04 - 8.58 
8.63 ± 1.1 
Range: 8.51 - 8.75 
P = 0.014 
Gestational age (weeks) 
 
33.3 ± 2.0 (n = 117) 
Range: 26 - 39 
34.0 ± 1.6 (n = 256) 
Range: 24 - 39 
P= 0.003 
APGAR after 5 minutes 
(score out of 10) 
8.74 ±1.43 
Range: 8.53 - 8.95 
9.12 ±0.58 
Range: 9.06 - 9.18 
P< 0.001 
Breastfeeding (%) 
(Number in group) 
     19.5% (n = 35)  64.4% (n = 210) P < 0.001 
Hospital stay (days):  
 
9.08 ± 21.63 
(5.92 - 12.25) 
3.61 ± 7.89 
(2.75 - 4.48) 
P < 0.001 
SMM= Substance Misusing Mothers 
 
